SWK Holdings Corporation (SWKH) Kapitalizatsiyaning foydaga nisbati

SWK Holdings Corp. (SWKH) brendining ramzi va logotipi

Swk Holdings Corp (SWKH) biotexnologiya sektoridagi strukturaviy kapitalga bo'lgan talab va aktivlarning qiymati oshishiga asoslangan barqaror daromadni keltirib chiqaradi, bu esa portfel boshqaruvidagi past operatsion xarajatlar tufayli yuqori masshtablanish imkoniyati bilan uyg'unlashgan. Bozor narxining harakati -75.40 ko'rsatkichi bilan aks etadi, kompaniyaning strategiyasi esa kreditlashni kengaytirish va istiqbolli hayot fanlari ishlab chiquvchilaridan royalti to'lovlarini sotib olishga tayanadi.

SWK Holdings (SWKH) - Narxning foydaga nisbati 21.02.2024dan 18.04.2026gacha

SWK Holdings Corp. (SWKH) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:SWKH - SWK Holdings Corporation
SWK Holdings yetakchi tovari

Swk Holdings Corp (SWKH) biotexnologiya sektoridagi ixtisoslashtirilgan kreditlash va royalti buybeklari orqali o'z kapitalizatsiyasini kengaytirmoqda. Ushbu strategiya P/E ko'rsatkichida aks etgan bo'lib, bunda aksiyalarning bozor qiymati bir aksiya uchun sof foyda bilan solishtiriladi. Ushbu ko'paytiruvchi investitsiyalarning qoplanish muddatini o'lchaydi va kelajakdagi daromadlar uchun to'langan premiumning miqdorini belgilaydi. Narx-foyda grafikasi tahlili orqali investor adolatli qiymat diapazonini aniqlaydi, bu esa eyforiya cho'qqilari paytida hissiyotlarga asoslangan xaridlarni bartaraf etadi.

Raqobatdosh kompaniyalar

ARCC (Ares Capital Corp) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati Blue Owl Capital (OBDC)|MAIN - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati fskkradvisor.com FSK|Kompaniya qiymatining sof foydaga nisbati GBDC|TSLX - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Goldman Sachs BDC Inc GSBD|PSEC (Prospect Capital BDC) - Narx-foyda koeffitsiyenti|Capital Southwest BDC - Kompaniya qiymatining sof foydaga nisbati|OCSL (Oaktree Specialty Lending Corp) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati trincapinvestment.com TRIN|Narxning foydaga nisbati midcapfinancialic.com (MFIC)|New Mountain Finance BDC (NMFC) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Carlyle Secured Lending Inc - Narx-foyda koeffitsiyenti|P/E multiplikatori PennantPark BDC PFLT|barings.com - P/E multiplikatori|Biznesning o‘zini qoplash muddati Bain Capital Specialty Finance, Inc. BCSF|SLRC (SLR Investment Corp.) - Narx-foyda koeffitsiyenti|FDUS: Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti MSIF|Kapitalizatsiyaning foydaga nisbati Carlyle Crescent BDC CCAP|P/E multiplikatori GAIN|gladstonecapital.com (GLAD) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori CION (CION Investment Corp)|PennantPark Investment Corp (PNNT) - Kapitalizatsiyaning foydaga nisbati|PSBD - Narxning foydaga nisbati|SAR - P/E multiplikatori|RWAY (investors.runwaygrowth.com) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati TPVG (TriplePoint Capital)|WHF (whitehorsefinance.com) - P/E multiplikatori|GECC (Great Elm Capital) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati ofscapital.com (OFS)|PFX: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori RAND (Rand Capital Inc)|ICMB - Narx-foyda koeffitsiyenti|EQS: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Logan Ridge Finance Corporation LRFC